FRANCISCO RODRIGUEZ: Open Payments
NPI 1457410649 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 18 payments from 8 companies in 2025. Trend: 2023 $82 · 2024 $949 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $116 |
| Axsome Therapeutics, Inc. | 3 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Corium, LLC | 1 | $21 |
| Validus Pharmaceuticals LLC | 1 | $18 |
Products named: CAPLYTA, Auvelity, REXULTI, AUSTEDO XR, SPRAVATO, INGREZZA, Azstarys, RALDESY.
Industry payments across FL — which companies pay providers there.
